-
公开(公告)号:DE3064096D1
公开(公告)日:1983-08-18
申请号:DE3064096
申请日:1980-05-05
Applicant: BASF AG
Inventor: STEINER GERD DR , FRANKE ALBRECHT DR , LENKE DIETER DR , TESCHENDORF HANS-JUERGEN DR , WORSTMANN WOLFGANG DR , KREISKOTT HORST DR
IPC: A61K31/55 , A61P25/18 , C07D223/20 , C07D401/06 , C07D403/04
Abstract: 6-Substituted 11-alkylene-morphanthridines, also referred to as 11-alkylene-dibenzo[b,e]-azepines, their pure cis- and trans-isomers, processes for their preparation, and therapeutic agents containing these compounds, which may be used as drugs, in particular neuroleptics, sedatives, hypnotics, analgesics, antidepressants or agents for treating Parkinson's syndrome.
-
公开(公告)号:DE2962856D1
公开(公告)日:1982-07-01
申请号:DE2962856
申请日:1979-12-21
Applicant: BASF AG
Inventor: TREIBER HANS JOERG DR , LENKE DIETER DR , WORSTMANN WOLFGANG DR
IPC: A61K31/55 , A61K31/553 , A61P25/04 , C07D267/10
Abstract: Novel hexahydro-1,4-oxazepines of the general formula I I where R1 is hydrogen, or alkyl or acyl each of 1 to 4 carbon atoms, R2 is alkyl of 1 to 4 carbon atoms and R3 and R4 are identical or different and each is hydrogen or methyl, and their salts with physiologically acceptable acids, processes for their preparation, drugs which contain these compounds, and their use in therapy. The compounds may be used for the pharmacotherapy of pain of various geneses.
-
3.
公开(公告)号:DE2966199D1
公开(公告)日:1983-11-10
申请号:DE2966199
申请日:1979-10-22
Applicant: BASF AG
Inventor: TREIBER HANS JOERG DR , LENKE DIETER DR , WORSTMANN WOLFGANG DR
IPC: A61K31/55 , A61K31/553 , A61P25/04 , C07D267/00 , C07D267/12 , C07D267/14
Abstract: PCT No. PCT/EP79/00080 Sec. 371 Date Jun. 26, 1980 Sec. 102(e) Date Jun. 16, 1980 PCT Filed Oct. 22, 1979 PCT Pub. No. WO80/00838 PCT Pub. Date May 1, 1980. The invention relates to novel 1,4-cycloalkano-oxazepines of the general formula where R1 is hydrogen, hydroxyl or alkoxy or acyloxy of 1 to 4 carbon atoms, R2 is a hydrocarbon radical of 1 to 3 carbon atoms, n is 1, 2 or 3 and x is 0 or 1, and of its salts with physiologically acceptable acids; processes for their preparation, and their use in therapy. The novel substances are suitable for the pharmacotherapy of pains of various origins.
-
公开(公告)号:DE2918778A1
公开(公告)日:1980-11-20
申请号:DE2918778
申请日:1979-05-10
Applicant: BASF AG
Inventor: STEINER GERD DIPL CHEM DR , FRANKE ALBRECHT DIPL CHEM DR , LENKE HANS-DIETER PROF DR , TESCHENDORF HANS JUERGEN DR , WORSTMANN WOLFGANG DR , KREISKOTT HORST DR
IPC: A61K31/55 , A61P25/18 , C07D223/20 , C07D401/06 , C07D403/04 , C07D498/04 , C07D401/04 , A61K31/395
Abstract: 6-Substituted 11-alkylene-morphanthridines, also referred to as 11-alkylene-dibenzo[b,e]-azepines, their pure cis- and trans-isomers, processes for their preparation, and therapeutic agents containing these compounds, which may be used as drugs, in particular neuroleptics, sedatives, hypnotics, analgesics, antidepressants or agents for treating Parkinson's syndrome.
-
公开(公告)号:DE3068880D1
公开(公告)日:1984-09-13
申请号:DE3068880
申请日:1980-09-11
Applicant: BASF AG
Inventor: WIERSDORFF WALTER-WIELANT DR , GEISS KARL-HEINZ DR , WEIFENBACH HARALD DR , WORSTMANN WOLFGANG DR , LENKE DIETER DR , KRETZSCHMAR ROLF DR
IPC: A61K31/27 , A61K31/325 , A61K31/34 , A61K31/341 , A61K31/357 , A61K31/38 , A61K31/381 , A61P25/20 , C07C45/62 , C07C45/69 , C07C45/75 , C07C45/79 , C07C45/81 , C07C49/21 , C07C49/337 , C07C49/345 , C07C49/543 , C07C49/553 , C07C49/573 , C07C67/00 , C07C68/02 , C07C68/06 , C07C69/96 , C07C239/00 , C07C271/06 , C07C271/08 , C07C313/00 , C07C319/20 , C07C323/43 , C07D307/14 , C07D307/22 , C07D307/52 , C07D309/04 , C07D309/14 , C07D317/28 , C07D319/06 , C07D333/20 , C07C125/063
Abstract: Novel carbamates derived from substituted cyclic beta -keto-alcohols, their preparation, and pharmaceutical formulations which contain these compounds and which may be used as hypnotics in the treatment of sleep disturbance and as sedatives.
-
6.
公开(公告)号:DE3163823D1
公开(公告)日:1984-07-05
申请号:DE3163823
申请日:1981-03-11
Applicant: BASF AG
Inventor: MAY HANS-JOACHIM DR , LENKE DIETER DR , GRIES JOSEF DR , TESCHENDORF HANS-JUERGEN DR , WORSTMANN WOLFGANG DR
IPC: C07D409/06 , A61K31/33 , A61K31/415 , A61K31/465 , A61K31/47 , A61P9/08 , A61P9/10 , A61P9/12 , A61P43/00 , C07D233/54 , C07D233/64 , C07D401/06 , C07D403/06 , C07D405/06 , C07D413/06 , C07D417/06
Abstract: 1-Aroyl-2-phenylamino-2-imidazolines of the general formula where R1 and R2 are identical or different and each is chlorine, bromine, fluorine, methyl, ethyl, methoxy, trifluoromethyl or cyano, R3 has the meanings given for R1 and R2 or is hydrogen and Ar is an unsubstituted or substituted monocyclic or bicyclic heteroaromatic radical containing 1, 2 or 3 nitrogen and/or oxygen and/or sulfur atoms, their salts with physiologically tolerated acids, their preparation, and drugs containing these compounds. The compounds have, inter alia, a blood pressure-reducing action.
-
公开(公告)号:GR73857B
公开(公告)日:1984-05-08
申请号:GR810164200
申请日:1981-02-20
Applicant: BASF AG
Inventor: MAY HANS-JOACHIM DR , LENKE DIETER PROF DR , GRIES JOSEF DR , TESCHENDORF HANS-JUERGEN DR , WORSTMANN WOLFGANG DR
IPC: C07D409/06 , A61K31/33 , A61K31/415 , A61K31/465 , A61K31/47 , A61P9/08 , A61P9/10 , A61P9/12 , A61P43/00 , C07D233/54 , C07D233/64 , C07D401/06 , C07D403/06 , C07D405/06 , C07D413/06 , C07D417/06
Abstract: 1-Aroyl-2-phenylamino-2-imidazolines of the general formula where R1 and R2 are identical or different and each is chlorine, bromine, fluorine, methyl, ethyl, methoxy, trifluoromethyl or cyano, R3 has the meanings given for R1 and R2 or is hydrogen and Ar is an unsubstituted or substituted monocyclic or bicyclic heteroaromatic radical containing 1, 2 or 3 nitrogen and/or oxygen and/or sulfur atoms, their salts with physiologically tolerated acids, their preparation, and drugs containing these compounds. The compounds have, inter alia, a blood pressure-reducing action.
-
公开(公告)号:DE3011327A1
公开(公告)日:1981-10-01
申请号:DE3011327
申请日:1980-03-24
Applicant: BASF AG
Inventor: MAY HANS-JOACHIM DIPL CHEM DR , LENKE DIETER PROF DR , GRIES JOSEF DR , TESCHENDORF HANS-JUERGEN DR , WORSTMANN WOLFGANG DR
IPC: C07D409/06 , A61K31/33 , A61K31/415 , A61K31/465 , A61K31/47 , A61P9/08 , A61P9/10 , A61P9/12 , A61P43/00 , C07D233/54 , C07D233/64 , C07D401/06 , C07D403/06 , C07D405/06 , C07D413/06 , C07D417/06 , C07D233/50 , C07D401/12 , C07D405/12 , C07D407/12 , C07D409/12 , A61K31/435 , A61K31/42 , A61K31/425
Abstract: 1-Aroyl-2-phenylamino-2-imidazolines of the general formula where R1 and R2 are identical or different and each is chlorine, bromine, fluorine, methyl, ethyl, methoxy, trifluoromethyl or cyano, R3 has the meanings given for R1 and R2 or is hydrogen and Ar is an unsubstituted or substituted monocyclic or bicyclic heteroaromatic radical containing 1, 2 or 3 nitrogen and/or oxygen and/or sulfur atoms, their salts with physiologically tolerated acids, their preparation, and drugs containing these compounds. The compounds have, inter alia, a blood pressure-reducing action.
-
-
-
-
-
-
-